Obesity Clinical Trial
Official title:
Changes in Thyroid Function Tests and Texture Following Bariatric Surgery Induced Weight Loss
This study is expected to provide novel data regarding potential structural and functional changes of the thyroid gland in morbidly obese adults following significant weight loss through bariatric surgery. These data will complement evidence from epidemiological studies regarding the association of obesity and alterations in thyroid function. Potentially this study may justify further longer-term studies regarding the effects of weight gain and/or weight loss on the morphology of the thyroid gland and could help to form recommendations regarding follow-up investigations for the thyroid in morbidly obese patients.
Alterations in thyroid function are reported in obesity. Thyroid hormones and
thyroid-stimulating hormone (TSH) concentrations have been variously described as normal,
elevated, or low in morbidly obese patients compared with normal weight controls. However, it
is a common observation that a significant proportion of patients with morbid obesity display
slightly increased serum levels of TSH, while even relatively mild elevations of serum TSH
are associated with an increase in the occurrence of obesity. Of note, abnormalities in
thyroid function and TSH mostly normalize after weight loss, suggesting that these
biochemical alterations are reversible. Despite uncertainty regarding the underlying
mechanisms, it has been suggested that neither autoimmunity nor iodine deficiency seems to
play a critical role. Several alternative mechanisms leading to hyperthyrotropinemia have
been hypothesized, which include impaired feedback due to decreased number of
triiodothyronine (T3) receptors in the hypothalamus, and variations in peripheral deiodinase
activity. Leptin, in addition to regulating body weight and satiation, has also been shown to
mediate the production of pro-TRH in cultured fetal rat hypothalamic neurons. Partial
regulation of TSH by leptin has been also reported in humans. In addition, peripheral thyroid
hormone metabolism appears to be reflected by the ratio of T3 to reverse T3 (rT3)
(T3/rT3-ratio). We have shown that the T3/rT3-ratio is significantly increased in insulin
resistant patients compared to their insulin sensitive partners despite comparable TSH
values. Given that obesity is strongly associated with insulin resistance, and thyroid
hormones are known to modulate carbohydrate metabolism, e.g. by affecting cellular glucose
uptake, possible changes in the T3/fT3 ratio following weight loss after bariatric surgery
could be of interest.
Data from cross-sectional studies further indicate that the thyroid structure of obese
patients can be also affected, independent of the existence of autoimmune thyroiditis as
indicated by the presence of auto-antibodies such as TPO. Ultrasound (US) scans are able to
accurately characterize the echographic structure of thyroid tissue, in addition to
estimation of thyroid volume and identification of non-palpable thyroid nodules. The typical
normal thyroid parenchyma has a distinct high echo density due to the follicle structure,
which contrasts well with tissue of the collar muscles. The interface between thyroid cells
and the colloid exhibits elevated acoustic impedance, causing high-frequency acoustic waves
to be reflected back to the US probe. However, in autoimmune thyroid diseases both
lymphocytic infiltration and disruption of normal tissue architecture cause a reduction in
thyroid echogenicity, whereas other tissues close by such as muscle tissue appear to remain
unaffected. Only few previous studies reported on the morphology of the thyroid gland in
adults with morbid obesity. Given that thyroid function has been reported to return to normal
after weight loss, research questions are also raised about the potential reversibility of
thyroid structural abnormalities following substantial weight loss in previously morbidly
obese patients.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |